Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simvastatin for Prognosis in Primary Sclerosing Cholangitis (PiSCATIN)
NCT04133792Phase 3Active, not recruiting
- Start
- Oct 2020
- Primary completion
- Mar 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of simvastatin in Primary Sclerosing Cholangitis (PSC). Started Oct 2020; status: active, not recruiting.
02
Drugs
simvastatin
03
Conditions
Primary Sclerosing Cholangitis (PSC)
Beyond the preview
Go deeper on NCT04133792.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04133792.